GSCs are the preferred candidates to recruit TAMs into the tumor growing mass, as they secrete several chemoattractant molecules like Interleukin (IL) 6, IL1β, VEGF, colony stimulating factor 1 (CSF1), CXCL12, and are able to induce their polarization into a pro-angiogenic and immunosuppressive phenotype, which favors tumor growth and escape from the immune surveillance (Lisi et al., 2017; Manini et al., 2018). The gene discussed is VEGFA; the disease is neoplasm.